Authors:
NEMUNAITIS J
POOLE C
PRIMROSE J
ROSEMURGY A
MALFETANO J
BROWN P
BERRINGTON A
CORNISH A
LYNCH K
RASMUSSEN H
KERR D
COX D
MILLAR A
Citation: J. Nemunaitis et al., COMBINED ANALYSIS OF STUDIES OF THE EFFECTS OF THE MATRIX METALLOPROTEINASE INHIBITOR MARIMASTAT ON SERUM TUMOR-MARKERS IN ADVANCED CANCER - SELECTION OF A BIOLOGICALLY-ACTIVE AND TOLERABLE DOSE FOR LONGER-TERM STUDIES, Clinical cancer research, 4(5), 1998, pp. 1101-1109
Authors:
NEMUNAITIS J
POOLE C
PRIMROSE J
ROSEMURGY A
MALFETANO J
BROWN P
BERRINGTON A
CORNISH A
LYNCH K
RASMUSSEN H
KERR D
COX D
MILLAR A
Citation: J. Nemunaitis et al., COMBINED ANALYSIS OF STUDIES OF THE EFFECTS OF THE MATRIX METALLOPROTEINASE INHIBITOR MARIMASTAT ON SERUM TUMOR-MARKERS IN ADVANCED CANCER - SELECTION OF A BIOLOGICALLY-ACTIVE AND TOLERABLE DOSE FOR LONGER-TERM STUDIES, Clinical cancer research, 4(5), 1998, pp. 1101-1109
Citation: S. Dannefaer et D. Kerr, CHARACTERIZATION OF VACANCIES IN AS-GROWN AND IRRADIATED DIAMONDS, DIAMOND AND RELATED MATERIALS, 7(2-5), 1998, pp. 339-341
Authors:
OLLIFF S
SEYMOUR L
POOLE C
DETAKATS P
ORME R
FERRY D
KERR D
Citation: S. Olliff et al., EVALUATION OF SMANCS YRENE-CO-MALEYL-HALF-N-BUTYLATE)-NEOCARZINOSTATIN) IN TREATMENT OF INOPERABLE HEPATOCELLULAR-CARCINOMA, Annals of oncology, 9, 1998, pp. 676-676
Authors:
AVERY L
BORSEY DQ
GREENE SA
GUMMERSON I
HAYES R
KERR D
LEAN MEJ
MARSHALL SM
MCINNES A
PIERCE M
ROLAND J
SINCLAIR AJ
TADMAN J
WALTON A
WILES P
Citation: L. Avery et al., BRITISH DIABETIC ASSOCIATION GUIDELINES ON GENETIC AND IMMUNE SCREENING FOR TYPE-1 DIABETES-MELLITUS, Diabetic medicine, 15(8), 1998, pp. 643-643
Authors:
KERR D
CAVAN DA
JENNINGS B
DUNNINGTON C
GOLD D
CRICK M
Citation: D. Kerr et al., BEYOND RETINAL SCREENING - DIGITAL IMAGING IN THE ASSESSMENT AND FOLLOW-UP OF PATIENTS WITH DIABETIC-RETINOPATHY, Diabetic medicine, 15(10), 1998, pp. 878-882
Authors:
COCCONI G
CUNNINGHAM D
VANCUTSEM E
FRANCOIS E
GUSTAVSSON B
VANHAZEL G
KERR D
POSSINGER K
HIETSCHOLD SM
Citation: G. Cocconi et al., OPEN, RANDOMIZED, MULTICENTER TRIAL OF RALTITREXED VERSUS FLUOROURACIL PLUS HIGH-DOSE LEUCOVORIN IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 16(9), 1998, pp. 2943-2952
Citation: D. Kerr et al., 7-ALKYLCARBONYLOXYMETHYL PRODRUGS OF THEOPHYLLINE - TOPICAL DELIVERY OF THEOPHYLLINE, International journal of pharmaceutics, 167(1-2), 1998, pp. 37-48
Authors:
BAKER J
BLEIBERG H
HUTCHISON G
JACKMAN A
KERR D
LABIANCA R
MACDONALD J
MEYER HJ
MINSKY B
NORDLINGER B
ROUGIER P
SMITS S
SOBRERO A
TAYLOR I
VERWEIJ J
Citation: J. Baker et al., AN INTERNATIONAL MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF ADVANCED COLORECTAL-CANCER (FIRST OF 2 PARTS) (REPRINTED FROM EUR-J-SURG-ONCOL, VOL 23, SUPPL A, AUGUST 1997), Annales chirurgiae et gynaecologiae, 87(3), 1998, pp. 255-264
Authors:
WILS J
SAHMOUD T
SOBRERO A
BLEIBERG H
AHMEDZAI S
BLAZEBY J
BLIJHAM G
CONROY T
CUNNINGHAM D
CURRAN D
DIAZRUBIO E
DUCREUX M
EVANS J
GLIMELIUS B
HUTCHINSON G
KERR D
KIEBERT G
KOHNE H
LABIANCA R
LANGENDIJK R
NITTI D
NORDLINGER B
ROUGIER P
SCHEITHAUER W
SCHMOLL HJ
VANCUTSEM E
WAGENER T
WILKE J
MARINUS A
THERASSE P
Citation: J. Wils et al., EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG, Tumori, 84(3), 1998, pp. 335-347
Citation: Na. Helsby et al., INHIBITION OF MOUSE AND HUMAN CYP 1A-DEPENDENT AND 2E1-DEPENDENT SUBSTRATE METABOLISM BY THE ISOFLAVONOIDS GENISTEIN AND EQUOL, Food and chemical toxicology, 36(5), 1998, pp. 375-382
Authors:
GOVES J
OLDRING JK
KERR D
DALLARA RG
ROFFE EJ
POWELL JA
TAYLOR MD
Citation: J. Goves et al., FIRST LINE TREATMENT WITH OMEPRAZOLE PROVIDES AN EFFECTIVE AND SUPERIOR ALTERNATIVE STRATEGY IN THE MANAGEMENT OF DYSPEPSIA COMPARED TO ANTACID ALGINATE LIQUID - A MULTICENTER STUDY IN GENERAL-PRACTICE/, Alimentary pharmacology & therapeutics, 12(2), 1998, pp. 147-157
Authors:
FLANAGAN D
WOOD P
SHERWIN R
DEBRAH K
KERR D
Citation: D. Flanagan et al., GIN AND TONIC AND REACTIVE HYPOGLYCEMIA - WHAT IS IMPORTANT - THE GIN, THE TONIC, OR BOTH, The Journal of clinical endocrinology and metabolism, 83(3), 1998, pp. 796-800
Authors:
WATSON JM
WEISS MJ
LUNT MJ
CAVAN DA
KERR D
Citation: Jm. Watson et al., DOES THE BRAIN BECOME TOLERANT TO SUSTAINED CAFFEINE USE - IMPLICATIONS FOR TREATMENT HYPOGLYCEMIA UNAWARENESS, Diabetologia, 41, 1998, pp. 934-934